Financials

News Discussions Technicals Seasonals

4883 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Modalis Therapeutics Corp. engages in the development of gene therapy drugs. It uses CRISPR-GNDM, a gene modulation technology that assists patients fighting with genetic disorders. The company was founded by Haruhiko Morita and Osamu Nureki in January 2016 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4883 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company